Onconetix
ONCO
2 hedge funds and large institutions have $2.37M invested in Onconetix in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
91% less capital invested
Capital invested by funds: $25.9M → $2.37M (-$23.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$5.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.04M |
| 2 |
HF
HRT Financial
New York
|
-$639K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$417K |
| 4 |
Goldman Sachs
New York
|
-$239K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$230K |
ONCO Hedge Fund Activity: Q2 2022 in Review
2 of the 5,958 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q2 2022, worth a combined $2.37M — down 91% from $25.9M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ONCO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $5.5M. The largest seller was Millennium Management, cutting an estimated $1.04M.
- 2 institutional investors held Onconetix (ONCO) as of Q2 2022, up from 1 in Q1 2022.
- Funds reported $2.37M of Onconetix stock for Q2 2022, down 91% quarter-over-quarter.
- 1 fund opened new Onconetix positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest Onconetix buyer in Q2 2022 was Sabby Management, an estimated $5.5M added.
- The largest Onconetix seller in Q2 2022 was Millennium Management, an estimated $1.04M sold.
Based on aggregated 13F filings for Q2 2022.